The European molecular oncology diagnostics market is experiencing significant growth, driven by several key factors. Elevated incidence rates of cancer across Europe, coupled with advancements in molecular diagnostic technologies, are stimulating demand for precise and accurate diagnostic tools. Furthermore, the adoption of personalized medicine a